Valeant Pharmaceuticals, Swedish Orphan Biovitrum deal

Valeant’s PharmaSwiss S.A. division granted Swedish Orphan Biovitrum exclusive rights to commercialize Relistor methylnaltrexone for opioid-induced constipation (OIC) in Western Europe, Czech Republ...